Sarah Krüg is CEO of CANCER101, a patient advocacy organization whose mission is to help patients and caregivers navigate the cancer journey and partner with their healthcare team to make informed decisions. Sarah is the founder of Health Collaboratory, a global healthcare transformation consultancy that creates impact through patient engagement strategies, medical education strategies for clinicians, and platforms that pave the path for co-design and collaboration in healthcare such as the Patient Shark Tank® and Patient Doctor Tango™. She is the also the Executive Director and Past President of the Society for Participatory Medicine, a patient: clinician member driven organization whose mission is to enable collaborative partnerships between patients and healthcare professionals. She is Research Chair of the Cancer Patient Education Network and serves on the board of the National Organization of Rare Diseases.
She previously held the position of Global Education Director in the Medical Education Group at Pfizer, as well as patient advocacy relations. She also established the Global Investigator Initiated Research Program at Pfizer. Prior to joining Pfizer, Sarah spearheaded the development of the Pediatric Disease Management clinical pathways and conducted clinical research at Memorial Sloan- Kettering Cancer Center.